NVR CLL
Generic Name: aliskiren/hydrochlorothiazide
Pill imprint NVR CLL has been identified as Tekturna HCT 150 mg-25 mg.
Tekturna HCT is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. There is positive evidence of human fetal risk during pregnancy.
Tekturna HCT 150 mg-25 mg is not subject to the Controlled Substances Act.
See also related documents.
Tekturna HCT Images
- Generic Name:
- aliskiren/hydrochlorothiazide
- Imprint:
-
NVR
CLL - Strength:
- 150 mg-25 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide
crospovidone
hypromelloses
ferric oxide red
lactose
magnesium stearate
microcrystalline cellulose
polyethylene glycol
povidone
magnesium silicate
titanium dioxide
wheat starch
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- 00078-0522
More Tekturna HCT resources
- Tekturna HCT
- Tekturna HCT (Wolters Kluwer)
- Tekturna HCT (Cerner Multum)
- Tekturna HCT (Micromedex) - Includes Dosage Information
- Tekturna HCT (FDA)


